: He served as a post-doctoral research fellow at the Mayo Clinic in Rochester, Minnesota , where he focused on the risk factors for cognitive dysfunction in patients with rheumatoid arthritis .
At Mayo, he worked under prominent mentorship to investigate systemic inflammation and accelerated brain aging. His core research concentrated on identifying risk factors for cognitive dysfunction, dementia, and Alzheimer's disease in individuals suffering from long-term rheumatoid arthritis (RA). Key Research and Clinical Contributions
in Ohio, where he continues to provide direct patient care while advancing his medical expertise. At the Forefront of Rheumatology Research
: Exercise is one of the most effective ways to boost brain-derived neurotrophic factor (BDNF), a protein that supports neuron health. Even low-impact activities like swimming or tai chi can make a difference. The Bottom Line
This solution moves away from predatory "loan sharks" and gives breathing room to actual job creators in rural and semi-urban India.
By integrating his international research experience with frontline clinical practice, Dr. Chanakya Kodishala is helping to shape a more comprehensive approach to internal medicine. His work reminds us that treating a patient means looking at the whole person—from their joint health to their cognitive well-being.
Involved in research regarding autoimmune disease management. Conclusion
in patients living with rheumatoid arthritis (RA). This research is vital for improving the quality of life for RA patients, who often face challenges beyond joint pain, including "brain fog" and other cognitive impairments. Key Contributions and Publications
Strong statistical associations have been noted between baseline anxiety, depression, and subsequent neurodegeneration in autoimmune cohorts. Global Contributions to Autoimmune and Viral Interaction
This research helped identify how lupus patients face heightened risks during pandemics, examining how disease activity and immunosuppressant treatments affect infection severity. Published Work and Academic Impact
: He served as a post-doctoral research fellow at the Mayo Clinic in Rochester, Minnesota , where he focused on the risk factors for cognitive dysfunction in patients with rheumatoid arthritis .
At Mayo, he worked under prominent mentorship to investigate systemic inflammation and accelerated brain aging. His core research concentrated on identifying risk factors for cognitive dysfunction, dementia, and Alzheimer's disease in individuals suffering from long-term rheumatoid arthritis (RA). Key Research and Clinical Contributions
in Ohio, where he continues to provide direct patient care while advancing his medical expertise. At the Forefront of Rheumatology Research Chanakya Kodishala
: Exercise is one of the most effective ways to boost brain-derived neurotrophic factor (BDNF), a protein that supports neuron health. Even low-impact activities like swimming or tai chi can make a difference. The Bottom Line
This solution moves away from predatory "loan sharks" and gives breathing room to actual job creators in rural and semi-urban India. : He served as a post-doctoral research fellow
By integrating his international research experience with frontline clinical practice, Dr. Chanakya Kodishala is helping to shape a more comprehensive approach to internal medicine. His work reminds us that treating a patient means looking at the whole person—from their joint health to their cognitive well-being.
Involved in research regarding autoimmune disease management. Conclusion Key Research and Clinical Contributions in Ohio, where
in patients living with rheumatoid arthritis (RA). This research is vital for improving the quality of life for RA patients, who often face challenges beyond joint pain, including "brain fog" and other cognitive impairments. Key Contributions and Publications
Strong statistical associations have been noted between baseline anxiety, depression, and subsequent neurodegeneration in autoimmune cohorts. Global Contributions to Autoimmune and Viral Interaction
This research helped identify how lupus patients face heightened risks during pandemics, examining how disease activity and immunosuppressant treatments affect infection severity. Published Work and Academic Impact